Commentary on Brothers et al.: The role of safer environment interventions in addressing injecting‐related bacterial and fungal infections.

The author comments on a study by T. D. Brothers and colleagues which illustrated how modifiable environments shape risk for injecting-related infections along a pathway from drug acquisition and injection to health outcomes following infections. Topics include forces that are driving bacterial and fungal-related infections and programs that may exert beneficial effect on the infection pathway though prevention and facilitate intervention to identify and treat injecting-related infections.